News Saleb-,Newspapers are usually issued daily or weekly. Cancro, nuova terapia genica: trasforma i linfociti in killer del tumore | News Today, Magazine News weekly, but they also had a magazine format. Newspapers with common interests usually publish news articles and articles about national and international news as well as local news. These include news events and personalities of the political, business and finance, crime, weather, and natural hazards; health and medicine, science, and computers and technology; Sports; and entertainment, community, food and cuisine, apparel and home fashion, and the arts.
A wide range of materials have been published in newspapers. In addition to news,Cancro, nuova terapia genica: trasforma i linfociti in killer del tumore | News Today ,information and opinions expressed above, including weather forecasts; Criticism and reviews Arts (including literature, film, television, theater, art, and architecture) and local services such as a restaurant; obituaries, notices of birth and graduation announcements; Entertainment features such as crossword puzzles, horoscopes, editorial cartoons, jokes, cartoons and comics; Advice column, food, and other columns; and a list of radio and television (program schedule). In the year 2017, newspapers can also provide information about new movies and TV shows available on streaming video services such as Netflix. The newspaper has been classified ad section in which people and businesses can buy a small ad to sell goods or services; In the year 2013, a large increase in internet sites to sell goods, such as Craigslist and eBay have caused ad sales are much less classified for newspapers.Cancro, nuova terapia genica: trasforma i linfociti in killer del tumore | News Today
Since 1983, it has been known mainly because of its annual report and rankings that influence in college and grad school, lies in most fields and subjects. U.s. News World Report is and academic institution is the oldest and most famous in America, [5] and covering the areas of business, law, medicine, engineering, social sciences, education and public affairs, in addition to many other areas. Print Edition] has consistently included in the list of national bestsellers, coupled with online subscriptions. Additional rankings published by U.s. News World Report and includes hospitals,Cancro, nuova terapia genica: trasforma i linfociti in killer del tumore | News Today, medical and specialty cars.
Cancro, nuova terapia genica: trasforma i linfociti in killer del tumore | News Today-News of the United States was founded in 1933 by David Lawrence (1888-1973), which also started the World Report in 1946. The two magazines are covering national and international news separately, but Lawrence combines them into news reports of U.S. in World and 1948 [1] and Later sold the magazine to its employees. Historically, this magazine tends to be a bit more conservative than the two main competitors, Time and Newsweek, and focus more on the story of economic, health, and education. It's also distancing news, entertainment and sports celebrities. [2] an important milestone in the history of the beginning of the magazine is including the introduction of the "Washington Whispers" column in 1934 and the column "News You Can Use" in 1952. [3] [4] in 1958, the circulation of the weekly magazine passed one million and two million in 1973. (
wikipedia) Cancro, nuova terapia genica: trasforma i linfociti in killer del tumore | News Today
Una nuova terapia genica contro il cancro che trasforma i linfociti in killer delle cellule tumorali. Il nuovo prodigioso trattamento, che ha già dato risultati insperati, si chiama Yescarta e viene dagli Stati Uniti, dove ha ricevuto il via libera della Food and Drug Administration, l’agenzia governativa che vigila sulla certificazione delle procedure sanitarie. La terapia potrà ora essere applicata a persone adulte che hanno già affrontato senza successo almeno due cicli di chemioterapia.
Yescarta è una forma di immunoterapia contro il
linfoma Non-Hodgkins, una forma di neoplasia maligna che attacca il tessuto linfatico. La cura è stata inizialmente studiata dal National Cancer Institute e poi sviluppata dalla Kite Pharma che ha foraggiato con propri fondi lo sviluppo delle ricerche ottenendone i diritti di sfruttamento.
E’ la seconda terapia genica approvata negli Usa. La primam che si chiama
Kymriah ed è di proprietà della Novartis, è stata approvata ad agosto. E’ indicata per bambini e giovanissimi affetti da forme aggressive di leucemia. Entrambi i trattamenti però al momento hanno costi proibitivi. Il costo di un ciclo di Yescarta si aggira intorno ai 370 mila dollari, per Kymriah ne servono 475mila ma Novartis ha promesso il farmaco gratis ai pazienti che non mostreranno miglioramenti entro un mese.
Si tratta di malati terminali che avevano pochissime probabilità di essere vivi a 6 mesi. Potenzialmente, negli Stati Uniti la cura per il linfoma Non-Hodgkins riguarderebbe circa 3.500 pazienti l’anno.
from INFORMAZIONE CONSAPEVOLE-Informazione Libera e Indipendente http://ift.tt/2yy0Nix
Cancro, nuova terapia genica: trasforma i linfociti in killer del tumore | News Today
Title :
Cancro, nuova terapia genica: trasforma i linfociti in killer del tumore | News Today
Source :
Cancro, nuova terapia genica: trasforma i linfociti in killer del tumore | News Today
News Info:
0 komentar:
Post a Comment